Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck obesity drug to continue at low dose

April 11, 2008
Research and Development, Sales and Marketing

New data suggests Merck's taranabant drug can help obese patients lose weight, but safety concerns look to be behind higher …

News

Study confers protective benefits on Micardis

April 4, 2008
Sales and Marketing cv

Boehringer Ingelheim's hypertension treatment Micardis has come out on top of Aventis's gold standard ACE inhibitor Tritace in a new …

News

UK clinical research is being transformed

April 4, 2008
Research and Development UK, clinical trials

Politicians have been talking, reports have been published, a series of initiatives have been launched and a fist full of …

Feature

Trial fails to enhance Inegy’s prospects

April 4, 2008
Sales and Marketing cv

Schering-Plough and Merck's much-touted anti-cholesterol combination Inegy has suffered a setback following a poor showing in the ENHANCE trial. Inegy …

News

Major leap in statin prescribing predicted

April 4, 2008
Sales and Marketing cv

News

Role of pharmacists to be extended

April 4, 2008

Pharmacists are to be given a greater role in patient treatment and promoting good health under new government plans. The …

News

Make Alzheimer’s a top research priority, says public

April 1, 2008

The British public wants a greater focus on research into Alzheimer's disease, according to an opinion poll conducted by the …

News

UCB’s Cimzia fails to appeal to European regulators

April 1, 2008
Sales and Marketing EU

UCB's Crohn's disease drug Cimzia has been denied European approval for a second time after regulators said lacked sufficient evidence …

News

Latest news from Datamonitor

March 31, 2008
Sales and Marketing

The impact of the US presidential race on healthcare IT The three leaders in the race for the US presidency; …

News

The role of audit in marketing excellence

March 28, 2008
Sales and Marketing audit, excellence, marketing

The goal for any business leader, whether they run a company, business unit or brand, should always be 100% alignment …

Feature

Gardasil licence extension gets priority FDA review

March 28, 2008
Sales and Marketing

Merck has received priority review status from the FDA for its application to extend the licence of its cervical cancer …

News

Accomplia gains limited NICE approval

March 28, 2008
Sales and Marketing

Sanofi-Aventis' weight-loss pill Acomplia has been approved for prescription on the NHS, but only for patients who fail to respond …

News

Merck’s hepatitis B vaccine trial on hold

March 28, 2008
Sales and Marketing

US regulators have placed a 'clinical hold' on one of the trials for Merck's hepatitis B vaccine Heplisav, raising questions …

News

Boehringer Ingelheim’s Pradaxa approved in Europe

March 28, 2008
Sales and Marketing

European regulators have approved Boehringer Ingelheim's novel anti-clotting pill Pradaxa, paving the way it to be launched in the coming …

News

Pharming’s orphan drug receives second setback in Europe

March 26, 2008
Sales and Marketing HAE, Pharming

Dutch biotech company Pharming has suffered a blow, after its lead product Rhucin was rejected by European regulators for a …

News

NHS Trusts to promote their services to the public

March 25, 2008
Medical Communications

All patients needing routine hospital care will soon be able to choose from any approved NHS trust in the country. …

News

Latest news from Datamonitor

March 25, 2008
Sales and Marketing em

Faced with dwindling growth rates in the US and Europe, drug companies are turning their attention towards emerging pharmaceutical markets …

News

Early access to experimental drugs for terminally ill

March 25, 2008
Sales and Marketing

Terminally ill cancer patients are to get early access to developmental drugs in a bid to halve the time it …

News

GSK consolidates Cervarix PR ahead of crucial vaccine decision

March 25, 2008
Medical Communications

GlaxoSmithKline has reorganised the PR support for its cervical cancer vaccine Cervarix, choosing just one agency to handle the UK …

News

Latest news from Datamonitor

March 20, 2008
Sales and Marketing

With pharmaceutical companies struggling to maintain pipelines and portfolios with products developed in-house, organizations are increasingly turning to licensing to …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026